title: Intravenous excretory urography using Optiray in office urology.
abstract: Experiences with the nonionic contrast medium Optiray 300 were analyzed in 120 consecutive patients who underwent intravenous urography. Allergic diathesis was recorded prior to the examination in 12.5% of the patients, pretreatment was given in only 3 cases. The clinical safety of Optiray was outstanding, no adverse reactions were noted. Diagnostic quality of the radiographs was excellent in 78% and good in 22% of the cases. Optiray is considered to be a safe and effective contrast agent for use in intravenous excretory urography.
authors.forename: P M
authors.initials: PM
authors.lastname: Koncz
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D012189:Retrospective Studies; D014283:Triiodobenzoic Acids / Q000008:administration & dosage*; D014567:Urography
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol